INTRODUCTION
MALDI Imaging is a novel and powerful tool for direct detection and localization of biomolecules [1] [2] [3] [4] [5] [6] . Developments in this field have led to the study and anatomical localization of drugs, lipids, peptides and proteins in tissue sections [3] [4] [5] [6] [7] [8] . This method eliminates time consuming and work intensive steps such as extraction, pre-purification or separation. Many successful applications of this technique have been undertaken recently. Of particular interest has been the application of MALDI imaging to the direct analysis of diseased tissues in order to hunt for specific biomarkers 4, 9 . The analysis of nucleotide sequences is difficult however, and presents a real challenge for mass spectrometry. Moreover, as for traditional MALDI analysis, MALDI Imaging of proteins has a restricted mass range, and low abundance proteins, such as membrane or high molecular weight proteins, are hard to detect 4-6, 9, 10 .
To overcome these problems, we proposed and developed a new concept of specific MALDI
Imaging called "Tag-Mass". This strategy is based on the indirect MALDI imaging of mRNA or proteins using a probe labeled with a photocleavable linker, which is cleaved by the MALDI UV laser, releasing a Tag molecule. The Tag is a known molecule with a characteristic mass that can be detected efficiently by MALDI-MS, thus allowing for molecular images to be obtained more accurately and efficiently. By combining this approach with in situ hybridization or immunocytochemical methods, we are able to obtain, in addition to the standard molecular images, specific transcriptomic and peptidomic/proteomic maps. Molecular distributions and correlation of transcriptome and proteome expression could lead to important advances in the field of medical research, allowing for faster diagnosis by correlating the presence of transcripts with the corresponding proteins. Toward these goals, we report here on the feasibility of a specific MALDI Tag 
Tag synthesis

Photocleavable tagged oligonucleotide
The peptide is synthesized on Symphony (Protein Technologies Inc.) and purified on a DeltaPak C18 15µm 100A column (Waters). The oligonucleotide is synthesized from 3' to 5' on Expedite (Applied BioSystem). The amine function with photocleavable linker is added in 5' before cleavage and deprotection. These steps are performed using a NH 4 OH 28% solution during 24 hours in the dark. The amino oligonucleotide is then purified on a Delta-Pak C18 15µm 300A column (Waters). The amino function of the oligonucleotide is coupled with a heterobifunctional reagent comprising a maleimide function. The maleimido oligonucleotide is solubilized in water and added to a 1.2 equivalent of peptide in solution. The mixture is stirred for 16 hours.
The oligo-peptide conjugate is then purified on a Delta-Pak C18 15µm 300A column (Waters) and characterized by MALDI-MS (see Mass Spectrometry section).
Photocleavable tagged antibody
Peptides were custom made by Eurogentec S.A. using solid phase peptide synthesis (SPPS) on a 0.25 millimole (mmole) scale using Fmoc (9-fluorenylmethyloxycarbonyl amino-terminus protection) standard synthesis protocols 4 equivalent of Fmoc-AA) with double coupling reactions (twice 40minutes ) using TBTU/NMM has activator on a Symphony ( Rainin Instrument Co, In order to prepare this triphosphate, a Fmoc protected CPG resin was required. The succinylate was prepared from GT115A (100mg). The sample was relatively pure but contained a small amount (by TLC) of a higher running non-tritylated compound (originates from the Sonogashira reaction and does not interfere with subsequent reactions and was not visible in the NMR spectra of the sample). Since it was not possible to purify the succinate, the reaction was modified slightly. It is normal to add 2 equivalents of succinic anhydride to the reaction to get quantitative yield but if this is not removed completely, the amino residues of the cpg resin can become blocked during functionalisation. Therefore, 1.5 equivalents were used since the exact purity of the product is undetermined. The reaction did not go to completion (from TLC this was more than 50%) by comparing the intensity of the components on the TLC by UV(254nm) and the intensity of the DMT cation on treatment with HCl fumes. Since the non-succinylated product will not react, the resin was functionalised using this mixture. The resin was prepared but the loading is very low, 5.4μmolg -1 (180mg).
The resin was detritylated using 2% TCA/DCM washed with DCM and the process repeated washing steps in PBS buffer, the sections for peroxydase ICC were incubated in chloronaphtol with 0.05% H 2 O 2 for detection. Reaction was stopped with several PBS and ultrapurewater baths. For FITC ICC, slices were prepared using phenylenediamine in glycerol. For photocleavable tagged antibody, tissues were rinced 3 times for 5 minutes with ultrapure water to remove salts, and sections were kept drying at room temperature before matrix application. Tissues were then, compared using microscopy.
Mass Spectrometry
Sample preparation for MALDI/MS analysis.
For classical analysis 1 µL of sample solution and 1 µL of matrix solution were mixed on the MALDI plate according to the procedure of the dried-droplet preparation. Each recorded mass spectrum results from the average of 100 laser shots.
Classical analysis in linear
MALDI-MS Direct Analysis and MALDI imaging
MALDI-TOF mass spectra and imaging were performed on a Voyager-DE STR mass spectrometer (Applied Biosystems, Framingham, MA, USA) with delayed extraction (DE) and a 337 nm pulsed nitrogen laser. For routine analysis, HCCA was used at concentration's of 10 mg/mL in ACN /H 2 O (2:1, v/v, 0.1% TFA) and 3HPA at 50mg/mL in H 2 0/ammonium citrate (100mM). For direct tissue analysis and MALDI imaging, HCCA was used at 10 mg/mL in ACN /H 2 O (2:1, v/v).
Matrix was applied onto the tissue using a micropipette (typically 20 µL for a whole rat brain slice)
and then dried at room temperature. External calibration was performed using a peptide mixture (1.6 µM bradykinin, 1.6 µM Substance P, 1.6 µM ACTH 18-39, 3.2 µM ACTH 7-38, 4.8 µM bovine Insulin and 4.8 µM bovine Ubiquitin in H 2 O). Slices were visualized in the mass spectrometer using a color CCD camera (SONY). Each recorded mass spectrum is the result of the average of 100 laser shots on the area of interest. Acquisition parameters were set as follow:
acceleration voltage: 25 kV, 1 st grid voltage: 94%, guide-wire voltage: 0.1%, extraction delay time:
200 ns.
Images were reconstructed using MALDI Imaging Tools (MIT, M. Stoeckli, Novartis Inc., Switzerland). 30 000 points covering the whole slice with 100 laser shots per position were scanned. From each position, the software measures an average mass spectrum with its coordinates on the slice.
RESULTS AND DISCUSSION
The Tag To solve these problems and to provide access to the full proteome and transcriptome for MALDI imaging, we have designed a new approach to the specific imaging of these molecules. This approach is based on the indirect detection of mRNA and proteins via a "Tagmass" indicator. The "Tag" is a small molecule of a mass that can be readily detected by MALDI. It is coupled to an appropriate probe by means of a linker that can be cleaved efficiently by the UVlaser irradiation during the MALDI procedure ( Figure 1A ). The approach can be applied in MALDI imaging by using specific probes that will target either mRNA or proteins in tissue wholemounts or slices. Tagged photocleavable linkers can be chemically attached to DNA, cDNA, singlestranded cRNA, or antibody probes. These probes can then be used with hybridization methods, such as like
In Situ Hybridization (ISH) for oligonucleotides probes 13 , or with epitope binding ImmunoCytoChemistry (ICC) for antibody probes to target mRNA or proteins, respectively 14 .
In MALDI, material ejection is promoted by laser irradiation and restricted to the area where the laser beam impacts the sample surface. The mass spectrum reflects the molecular composition of the tissue in this specific site. If the tagged probe hybridizes to its complementary mRNA sequence, then the laser irradiation will photocleave the linker, inducing tag release, leading to a characteristic signal of known mass. At positions where no target mRNA are present, the characteristic signal for the tag will not be observed. Thus, as in standard MALDI imaging, scanning the tissue section, images of mRNAs can be obtained indirectly by reconstructing the molecular image of the tag molecule on the basis of its mass signal mass data. This approach brings mass spectrometry's sensitivity and the possibility of multiple imaging at once using multiple tags ( Figure 1B ).
The same strategy can be adapted for mapping target proteins using tagged antibodies in combination with ICC experiments. A specific tagged antibody can be used for indirect experiments. However, in our opinion, addition of the linker and tag on a secondary antibody recognizing the C-terminus of a primary antibody is easier to use and allows for signal amplification. Thus, as for ICC experiments, a primary antibody will specifically bind its target antigen. The tagged secondary antibody will then specifically recognize the first one Then, as for mRNA, the scanning of the tissue sections by MALDI MS will allow indirect detection of the protein by monitoring the tag in the mass spectra. As for oligonucleotides, multiple different protein specific images can be obtained by MALDI in one experiment by using directly tagged primary with different peptides or secondary antibodies developed in different animal species.
Inherent in this approach to specific molecular imaging of mRNA and proteins are the sensitivity and multiplex possibilities of mass spectrometry. It should be of great interest for transcriptome/proteome co-localization mapping, and will find application when and where colocating a protein and its corresponding mRNA are important. In particular, it may permit mapping in tissues and slices the heterogeneous distribution of localized transcriptional regulation by monitoring the relative levels of a transcript and the corresponding protein.
Photocleavable tagged oligonucleotide probes: mRNA MALDI imaging
As a first step 15 , the performance of photocleavage dissociation by MALDI UV laser was evaluated for oligonucleotides. A photocleavable linker was bound to the 5' oligonucleotide end and peptides were chosen as tags and photodissociation was assumed to induce cleavage directly between the phosphate group and the photoactivable linker ( Figure 3 ). As shown in were especially intense for one of the peptides. For subsequent experiments, bradykinin was selected because it gives the best sensitivity (100 fmoles) and ease of detection in all analytical conditions (P3).
To increase sensitivity by suppressing fast fragmentation signals a new photocleavable linker/tag system was designed replacing the disulfide bridge by a maleimide group for binding the tag peptide to the photocleavable linker ( Figure 5 ). Studies performed on this structure clearly demonstrate the suppression of fast fragmentation signal and increase of the expected signal for photocleavage. This photocleavable linker/tag system was used to construct double-stranded cDNA oligonucleotidic probes. Proenkephalin was chosen as the model target mRNA because previous studies gave low background for this molecule's mRNA distribution in the rat brain 16 . Standard untagged and tagged primers bearing the photocleavable linker/tag system were added to the proenkephalin cDNA sequence. Both types of primers were used for RT-PCR amplification and have given the same results in terms of product and yield of amplification. RT-PCR was used to make a 400 bp double-stranded cDNA oligonucleotidic probe (data not shown). The probe was tested in ISH experiments and followed by MALDI analysis of hybridized rat brain tissue sections for tag detection. The mass spectra obtained clearly demonstrated the possibility of detecting the characteristic ion signal for the tag in some specific region of the section hybridized with the tagged probes. This signal was never found for control tissue sections where the untagged proenkephalin probes were used. However, signal intensity for the tag was weak and somewhat lacking in sensitivity, although the feasibility of the proposed strategy was unambiguously demonstrated.
Therefore, the strategy was slightly modified in order to improve sensitivity, increase specificity and facilitate usage.
An alternative approach using dUTP-TAG was developed, based on the labeling of uracil with the same photocleavable linker/tag system described above. This new design keeps both the 5' and 3' ends of the nucleotide free, allowing the synthesis of riboprobes containing the modified base by in vitro translation. This first step increases the specificity of the method, thus preventing non specific binding to genomic DNA. Moreover, use of a tagged nucleotide leads to the incorporation of one tag for each T nucleotide (Figure 6 ), increasing sensitivity. Finally, the use of tagged nucleotides has the very practical consequence, that these nucleotides can be incorporated using standard procedures, regardless of the probe being amplified.
The dU-tagged nucleotides were tested for photocleavage, as shown in Figure 7 . Again, the characteristic signal of the tag peptide was observed (m/z 1163.23), with very good S/N ratio and signal intensity, demonstrating that the maleimide group incorporation prevents fast fragmentation.
The dU-tagged system was used for amplifying the proenkephalin probe by RT-PCR. As expected from the structure (Figure 8 ) and previously described for dUTP-DIG systems 17 (Ree et al., 1992), dNTP ratios had to be optimized, with best results obtained with dU-TAG and dTPP in a ratio of 1:3. ISH was performed with the multiple tagged proenkephalin amplified probes. MALDI analysis of the hybridized rat brain tissue sections was then carried out and compared to the analysis of adjacent tissue sections hybridized with untagged proenkephalin probe amplified in the same conditions but with unmodified dNTP (Figure 9 ). The characteristic signal of the tag peptide was observed in rat brain tissue for the multiply-tagged proenkephalin probe, whereas this signal never appeared when the untagged probe was used. As expected, mass spectra reveal a clear increase in detection of the ion corresponding to the tag peptide. MALDI imaging was subsequently performed on this tissue section by scanning the tissue and recording corresponding mass spectra (7000 spots, 100 µm steps) ( Figure 10 ). Based on the characteristic tag signal (Figure 9b ), an image of the molecular distribution of proenkephalin mRNA was reconstructed, as presented in Figure 10d . The image fits the tissue morphology well (Figure 10c ) and matches the proenkephalin mRNA distribution obtained by ISH with autoradiography 18 or the one obtained in mouse brain with digoxigenin probe 19 ( Figure 10b) . These experiments clearly demonstrate the feasibility of specific mRNA imaging by MALDI mass spectrometry.
Photocleavable tagged antibody probes for antigen MALDI imaging
The same concept was applied in obtaining specific images of proteins using tagged secondary protein is detected in the same brain area using both methods, thus validating the methodology.
However, in some specific areas, such as the hypocampus, CPD was detected with the tag-mass system while no signal was detected with the colorimetric reaction, indicating that the indirect detection by mass spectrometry is much more sensitive than classic techniques (Figure 12a ).
Comparing the MALDI image of CPD to the fluorescence image obtained from the section on which FITC antibody was used, MALDI appears to be as sensitive as fluorescence (Figure 12c 
CONCLUSION
We have demonstrated here the application of a new concept for specific imaging of mRNA and proteins, using MALDI mass spectrometry to image target molecules in sectioned tissue. This strategy relies on targeting specific biomolecules with probes that contain a photocleavable linker and a tag moiety that can be photodissociated by MALDI laser irradiation. We have successfully tested this strategy with peptide tags on oligonucloeotide and antibody probes. With this method, we were able to image a 180 kDa membrane protein and proenkephalin mRNA. For oligonucleotides, U-tagged nucleotide probes were found to be the best choice for increased sensitivity and flexibility. Mass spectrometric detection was shown to be very sensitive, yielding distributions of the molecules of interest on whole tissue sections with more sensitivity than most of the classical methods using peroxydase as a substrate, and giving highly resolved images of molecules that could not be observed directly by MALDI imaging. However, method sensitivity could still be increased by using multiplex experiments with several different tags. Image resolution could also be improved and is currently under development. This strategy can also be extended to other types of probes, including lectins or aptamers, which will also allow for the imaging of polysaccharides, peptides, proteins or drugs ( Figure 13 ). It will also be possible to develop different families of tags that will give better signal detection by MALDI. Thus, MALDI matrices or compounds absorbing at the laser wavelength and possibly detectable by Laser Desorption Ionization (LDI) will be investigated in order to acquire images without the need for the matrix.
Finally, photocleavage is a very elegant strategy but linkers that would dissociate by prompt fragmentation during the desorption/ionization process could be a good alternative. Linker dissociation by fragmentation could perhaps lead to a higher tag release rate. Moreover, using such linkers could extend the concept from UV-to IR-MALDI, or even to SIMS mass spectrometry for specifically designed linkers and tags, depending on the ion production method used. SIMS applications would also be very attractive, as SIMS imaging allows subcellular probing (classically 1 µm resolution), however, currently SIMS is limited to monoatomic elements or small organic compounds such as lipids. Finally, Tag-mass could open a great opportunity for mass spectrometry to image all biomolecules present in tissues, with a very high sensitivity and without being restricted by low abundance or size. In addition, specific imaging could be used for relative quantification of target molecules. The use of tags that differ from each other only in isotopic composition (e.g. deuterated molecules) and hence behave similarly when analyzed by MALDI would open the way for quantification by MALDI imaging. Finally, the concept could also be transferred to microarrays for more quantitative and specific detection.
Tag-mass strategies provide a unique opportunity to obtain transciptome/proteome colocalization maps, providing very useful information on biological processes, .e.g., for diagnostic screening of the transcript before the synthesis of the corresponding protein. Extending MALDI imaging to specific aptamer probes, for example, will also allow for the co-localizion of a drug and its assumed receptor target.
FIGURE LEGENDS FIGURE 1:
A. Schematic representation of the concept of MALDI imaging of mRNA using tagged oligonucleotide probes for detection by photocleavage.
B. Scheme of the photcleavable linker/tag system for indirect detection after photodissociation under the MALDI UV laser wavelength.
FIGURE 2:
Developed structure of the oligonucleotide tagged by the photocleavable linker tag/system intact and after photodissociation under the MALDI laser.
FIGURE 3:
MALDI mass spectrum in the linear positive mode of an oligopeptide including a 20 mer oligonucleotide sequence and the photocleavable tag/system with 3-HPA as matrix.
FIGURE 4:
MALDI mass spectrum in the reflectron positive mode of three oligopeptides including three different 20 mer oligonucleotides and the photocleavable linker/tag system with three different peptides as tags with HCCA as matrix.
FIGURE 5:
Developed structure of the oligonucleotide tagged by the photocleavable linker/tag system with a maleimide group for bonding to the tag peptide structure.
FIGURE 6:
A. Scheme of the incorporation of the tagged U nucleotide in a single strand RNA probe.
B.
Developed structure of the U-tagged nucleotide
FIGURE 7:
MALDI mass spectrum in the reflectron positive mode of the U-tagged nucleotide in solution with HCCA as matrix.
FIGURE 8:
Developed structure of the photocleavable linker/tag system modified secondary antibody with the U-tagged proenkephalin probe (7000 spots separated each of 100 µm).
FIGURE 11 :
Compared MALDI mass spectra in the linear positive mode recorded on two adjacent rat brain sections in the same region of the brain after ICC experiment with a primary antibody directed against carboxypeptidase D protein and a rabbit FITC polyclonal secondary antibody labeled with a FITC (a) or bearing the photocleavable linker/tag system (b).
FIGURE 12 :
Rat brain tissue section picture before the ICC experiment and corresponding MALDI molecular image reconstructed on the tag peptide characteristic ion screening after ICC experiment with the tagged secondary antibody (30000 spots separated each of 100 µm) (a,b) and comparison to pictures of specific region of the adjacent rat brain sections after ICC experiment with FITC (c,d) or peroxydase (e) secondary antibody.
FIGURE 13:
Schematic representation of the concept of specific imaging for different target biomolecules and probes. 
